• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Hypoxic, Ventilatory Burdens in OSA Predict CVD Morbidity and Mortality

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, Aug. 1, 2023 -- Hypoxic and ventilatory burden in obstructive sleep apnea predict cardiovascular disease morbidity and mortality, according to a study published online July 7 in the American Journal of Respiratory and Critical Care Medicine.

Gonzalo Labarca, M.D., from Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues examined the association of hypoxic burden with incident cardiovascular disease (CVD) compared to that of ventilatory burden and arousal burden in obstructive sleep apnea. Hypoxic, ventilatory, and arousal burdens were measured from baseline polysomnograms in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Osteoporotic Fractures in Men (MrOS) studies. Ventilatory burden was defined as event-specific area under ventilation signal, while arousal burden was defined as normalized cumulative duration of all arousals.

The researchers found significant associations for hypoxic and ventilatory burdens with incident CVD (adjusted hazard ratio per 1 standard deviation increase in hypoxic burden: 1.45 and 1.13 for MESA and MrOS, respectively; ventilatory burden: 1.38 and 1.12 for MESA and MrOS, respectively); no association was seen for arousal burden. There were similar associations observed for mortality. Ventilatory burden explained 78 percent of the variation in hypoxic burden, while other factors explained less than 2 percent of the variation.

"We think that including a higher-risk version of obstructive sleep apnea in a randomized clinical trial would hopefully show that treating sleep apnea could help prevent future cardiovascular outcomes," coauthor Ali Azarbarzin, Ph.D., also of Brigham and Women's Hospital and Harvard Medical School, said in a statement.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.